Cargando…
MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells
A key principle of oncolytic viral therapy is that many cancers develop defects in their antiviral responses, making them more susceptible to virus infection. However, some cancers display resistance to viral infection. Many of these resistant cancers constitutively express interferon-stimulated gen...
Autores principales: | Bayne, Robert S., Puckett, Shelby, Rodrigues, Lindsey Ulkus, Cramer, Scott D., Lee, Jingyun, Furdui, Cristina M., Chou, Jeff W., Miller, Lance D., Ornelles, David A., Lyles, Douglas S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276393/ https://www.ncbi.nlm.nih.gov/pubmed/32529027 http://dx.doi.org/10.1016/j.omto.2020.05.004 |
Ejemplares similares
-
Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells
por: Kim, Teddy E., et al.
Publicado: (2021) -
Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin
por: Westcott, Marlena M., et al.
Publicado: (2018) -
Vesicular stomatitis virus nucleocapsids diffuse through cytoplasm by hopping from trap to trap in random directions
por: Holzwarth, George, et al.
Publicado: (2020) -
Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy
por: Simovic, Boris, et al.
Publicado: (2015) -
Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
por: Muik, Alexander, et al.
Publicado: (2012)